Latest posts
-
Bristol Myers Exceeds Q3 Revenue Projections Fueled by Strong Opdivo Sales
Bristol Myers Squibb outperformed Wall Street’s revenue expectations for the third quarter, primarily driven by robust sales of its cancer immunotherapy Opdivo and the blood thinner Eliquis. This performance, which saw shares rise 2% in premarket trading, enabled the company to counterbalance the impact of generic competition on several older medications. Additionally, Bristol Myers raised…
-
Belden Reports Third Quarter Earnings
ST. LOUIS (AP) — Belden Inc. (BDC) announced on Thursday a third-quarter profit of $56.7 million, translating to earnings of $1.41 per share. When adjusted for one-time gains and expenses, earnings rose to $1.97 per share. The communications equipment company generated revenues of $698.2 million during the quarter. Looking ahead to the current quarter ending…
-
Hilton Grand Vacations Reports Q3 Earnings Results
ORLANDO, Fla. (AP) — Hilton Grand Vacations Inc. (HGV) announced its third-quarter earnings on Thursday, revealing a net income of $25 million. The company, based in Orlando, Florida, reported earnings of 28 cents per share, while adjusted earnings, excluding one-time costs, amounted to 60 cents per share. These results fell short of Wall Street’s expectations,…
-
Initial Insights: XPO’s Q3 Earnings Report
On Thursday, prior to market opening, XPO announced third-quarter results that surpassed expectations. Enhanced efficiency measures and improved yields drove an increase in operating income for the company’s less-than-truckload division, located in Greenwich, Connecticut. XPO (NYSE: XPO) posted adjusted earnings per share of $1.07 for the quarter, exceeding both consensus estimates and last year’s figures…
